Chemotherapy Induced Anemia - Pipeline Review, H2 2011

Published : October 2011
No. of Pages : 49

Price:

Summary

Global Markets Direct’s, 'Chemotherapy Induced Anemia - Pipeline Review, H2 2011', provides an overview of the Chemotherapy Induced Anemia therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Anemia. 'Chemotherapy Induced Anemia - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Chemotherapy Induced Anemia.
- A review of the Chemotherapy Induced Anemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Chemotherapy Induced Anemia pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Chemotherapy Induced Anemia.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Chemotherapy Induced Anemia pipeline depth and focus of Chemotherapy Induced Anemia therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Chemotherapy Induced Anemia Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Chemotherapy Induced Anemia 8
Chemotherapy Induced Anemia Therapeutics under Development by Companies 10
Chemotherapy Induced Anemia Therapeutics under Investigation by Universities/Institutes 12
Late Stage Products 13
Comparative Analysis 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Early Clinical Stage Products 15
Comparative Analysis 15
Pre-Clinical Stage Products 16
Comparative Analysis 16
Chemotherapy Induced Anemia Therapeutics - Products under Development by Companies 17
Chemotherapy Induced Anemia Therapeutics - Products under Investigation by Universities/Institutes 18
Companies Involved in Chemotherapy Induced Anemia Therapeutics Development 19
Kyowa Hakko Kirin Co., Ltd. 19
3SBio Inc. 19
ProMetic Life Sciences Inc. 20
Sinobiomed, Inc. 20
Acceleron Pharma, Inc. 21
Orcrist Bio Inc. 21
Therapure Biopharma Inc. 22
Chemotherapy Induced Anemia - Therapeutics Assessment 23
Assessment by Monotherapy Products 23
Assessment by Combination Products 24
Assessment by Route of Administration 25
Assessment by Molecule Type 27
Drug Profiles 29
ACE-011 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
NuPIAO - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Rh-SCF - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
PBI-1402 - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
HYC750 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Epoetin alfa + Cisplatin + Brachytherapy + Radiation therapy - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
NESP - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
PanCyte + Erythropoietin - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Epoetin Beta - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
TBI 304 - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Chemotherapy Induced Anemia Therapeutics – Drug Profile Updates 39
Chemotherapy Induced Anemia Therapeutics - Discontinued Products 40
Chemotherapy Induced Anemia - Featured News 41
Oct 10, 2011: Affymax And Takeda to Present Peginesatide Data at the American Society of Nephrology Kidney Week 2011 41
Sep 30, 2011: Chugai Pharmaceutical Announce Results Of Pharmaceutical Affairs Subcommittee Regarding Application Of Epogin For Chemotherapy Induced Anemia 42
Jun 02, 2011: Acceleron And Celgene Initiate Phase II/III Study Of ACE-011 To Treat Chemotherapy-Induced Anemia In Patients With Lung Cancer 42
Jun 18, 2010: Chugai Pharmaceutical Co., Ltd Got Recombinant Human Erythropoietin, “EPOGIN Subcutaneous Injection Syringe 24000,” Approved In Japan 43
Jun 06, 2010: Alder's ALD518 Antibody Therapeutic Reduces Disease Symptoms, Anemia In Phase IIa Clinical Trial In NSCLC Patients 43
Mar 02, 2010: Lipoxen Initiates Phase II Trial Of ErepoXen In India 44
Dec 01, 2009: Acceleron Pharma To Present Clinical Trial Results Of ACE-011 At The 51st Annual Meeting Of The American Society Of Hematology 45
Jul 28, 2009: Acceleron and Celgene Initiate Phase II Study of ACE-011 to Treat Chemotherapy-Induced Anemia 45
May 06, 2009: Lipoxen Plc Announces Positive Phase I Clinical Trial Results For ErepoXen 46
Jun 16, 2008: Lipoxen Receives Approval To Conduct Second Phase I Trial Of Its Long-Acting Erythropoietin (EPO), ErepoXen, In Canada 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 49
Contact Us 49
Disclaimer 49

Chemotherapy Induced Anemia - Pipeline Review, H2 2011

Published By: Global Markets Direct

Price:

How to Purchase

Purchase products from our site in 5 easy steps. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .

sales@marketreportsonline.com + 1 888 391 5441

Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option

Get Email alerts about market research reports from industries and publishers of your interest: